{
    "pmcid": "11528319",
    "qa_pairs": {
        "What is the primary function of the GraphRBF model introduced in the paper?": [
            "To predict binding sites on proteins with high accuracy and interpretability.",
            "To simulate the folding process of proteins in different environments.",
            "To sequence the genome of SARS-CoV-2 variants.",
            "To design new drug molecules from scratch using AI."
        ],
        "What potential application does the GraphRBF model have in therapeutic development against SARS-CoV-2?": [
            "Designing new nanobodies that could neutralize SARS-CoV-2 variants",
            "Developing antiviral drugs that inhibit viral replication",
            "Creating vaccines that target viral RNA directly",
            "Engineering enzymes to degrade the viral capsid"
        ],
        "What type of networks does the GraphRBF model integrate to predict protein binding sites?": [
            "Graph neural networks (GNNs) and radial basis function networks",
            "Convolutional neural networks (CNNs) and recurrent neural networks (RNNs)",
            "Support vector machines (SVMs) and decision trees",
            "Bayesian networks and Markov models"
        ],
        "Which domains of the SARS-CoV-2 spike protein did GraphRBF highlight as critical for neutralizing antibodies?": [
            "N-terminal domain (NTD) and receptor-binding domain (RBD)",
            "Membrane fusion domain and heptad repeat domain",
            "Transmembrane domain and cytoplasmic tail",
            "Signal peptide and S1/S2 cleavage site"
        ],
        "Which specific variant of the SARS-CoV-2 spike protein was the GraphRBF model applied to?": [
            "Omicron variant",
            "Delta variant",
            "Alpha variant",
            "Beta variant"
        ]
    }
}